ENDPQ — Endo International Share Price
0.000.00%
Last trade - 00:00- $0.14m
- $7.37bn
- $2.01bn
- 26
- 92
- 15
- 41
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 0 | ||
| Price to Sales | 0 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -52% | ||
| Return on Equity | n/a | ||
| Operating Margin | -118.88% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 2,914.36 | 2,903.07 | 2,993.21 | 2,318.88 | 2,011.52 | n/a | n/a | -7.35% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Endo International plc has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code and is winding down its business. The Company has no business operations.
Directors
- Mark Barberio NEC (58)
- Blaise Coleman PRE (47)
- Mark Bradley CFO
- Patrick Barry EVP (53)
- Matthew Maletta EVP (50)
- Jack Boyle SVP (45)
- Jennifer Chao IND (51)
- Shane Cooke IND (58)
- Nancy Hutson IND (71)
- Michael Hyatt IND (75)
- William Montague IND (74)
- M. Christine Smith IND (56)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- October 31st, 2013
- Public Since
- March 3rd, 2014
- No. of Shareholders
- 199
- No. of Employees
- 2,931
- Sector
- Holding Companies
- Industry
- Financials
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 235,219,612
- Address
- Minerva House, Simmonscourt Road, DUBLIN, 000 00
- Web
- http://www.endo.com/
- Phone
- +353 12682000
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for ENDPQ
Q2 2024 Endo International PLC Earnings Release
Similar to ENDPQ
1399 Internet Technology Application
Pink Sheets on Nasdaq
3D Pioneer Systems
Pink Sheets on Nasdaq
9 Meters Biopharma
Pink Sheets on Nasdaq
Absolute Health and Fitness
Pink Sheets on Nasdaq
ACC Aviation Holdings
Pink Sheets on Nasdaq
FAQ
What is the Endo International share price?
As of Today at 19:07 UTC, shares in Endo International are trading at $0.00. This share price information is delayed by 15 minutes.
How has the Endo International share price performed this year?
Shares in Endo International last closed at $0.00 and the price had moved by -99.04% over the past 365 days. In terms of relative price strength the Endo International share price has underperformed the S&P500 Index by -99.17% over the past year.
What are the analyst and broker recommendations for Endo International?
The overall consensus recommendation for Endo International is Sell. You can view the full broker recommendation list by unlocking its StockReport.
What is the Endo International dividend yield?
Endo International does not currently pay a dividend.
Does Endo International pay a dividend?
Endo International does not currently pay a dividend.
When does Endo International next pay dividends?
Endo International does not currently pay a dividend.
How do I buy Endo International shares?
To buy shares in Endo International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Endo International?
As of the previous close price of $0.00, shares in Endo International had a market capitalisation of $0.14m.
Where are Endo International shares listed?
Here are the trading details for Endo International:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: ENDPQ
What kind of share is Endo International?
Based on an overall assessment of its quality, value and momentum Endo International is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Endo International share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Endo International share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Endo International. Over the past six months, its share price has underperformed the S&P500 Index by -91.66%.
As of the last closing price of $0.00, shares in Endo International were trading -87.81% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Endo International PE Ratio?
The Endo International PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Endo International?
Endo International's management team is headed by:
- Mark Barberio - NEC
- Blaise Coleman - PRE
- Mark Bradley - CFO
- Patrick Barry - EVP
- Matthew Maletta - EVP
- Jack Boyle - SVP
- Jennifer Chao - IND
- Shane Cooke - IND
- Nancy Hutson - IND
- Michael Hyatt - IND
- William Montague - IND
- M. Christine Smith - IND